Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
CNY 2.22
(0.45%)
CNY 2.22
(0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 200.75 Million | 2.64 Billion | 3.19 Billion | 368.85 Million | 162.92 Million | 944.39 Million |
| Net Income | 1.28 Billion | 3.81 Billion | 3.03 Billion | 2.9 Million | 506.61 Million | 298.2 Million |
| Depreciation & Amortization | 1 Billion | 929.59 Million | 643.93 Million | 642.95 Million | 635.59 Million | 575.12 Million |
| Deferred income taxes | 80.78 Million | -28.43 Million | 97.64 Million | -47.9 Million | 1.67 Million | 2.38 Million |
| Stock-based compensation | 29.79 Million | 506.48 Million | - | - | - | - |
| Change in working capital | -2.28 Billion | -2.17 Billion | -543.51 Million | -364.17 Million | -1.06 Billion | -160.26 Million |
| Other non-cash items | 4.4 Billion | -395.85 Million | 64.96 Million | 87.16 Million | 84.99 Million | 231.33 Million |
| Investing Cash Flow | -902.65 Million | -807.24 Million | -1.72 Billion | -210.37 Million | -1.27 Billion | -320.3 Million |
| Investments in PPE | -828.73 Million | -936.18 Million | -1.73 Billion | -197.09 Million | -662.54 Million | -363.56 Million |
| Acquisitions | 91.16 Million | 4 Million | 17.9 Million | -2.41 Million | -643.92 Million | 237.71 Thousand |
| Investment purchases | -165.04 Million | 0.69 | -57.48 Million | -352.15 Million | -332.81 Million | -86.19 Million |
| Sales/Maturities of investments | 120.42 Million | 62.28 Million | 51.82 Million | 336.54 Million | 280.47 Million | 132.36 Million |
| Other Investing Activities | -36.3 Thousand | 62.65 Million | 334.31 Thousand | 4.74 Million | 82.42 Million | -3.15 Million |
| Financing Cash Flow | -943.59 Million | 1 Billion | -619.36 Million | 78.44 Million | 367.06 Million | -160.02 Million |
| Debt repayment | -147.11 Million | -1.29 Billion | -2.07 Billion | -1.63 Billion | -1.06 Billion | -1.92 Billion |
| Dividends payments | -392.63 Million | -130.87 Million | -77.98 Million | -92.74 Million | -71.1 Million | -253.24 Million |
| Common Stock Repurchased | -500.36 Million | -668.69 Million | -179.92 Million | -120.07 Million | -250 Million | -149.99 Million |
| Common Stock Issuance | - | 668.69 Million | 179.92 Million | 120.07 Million | 250 Million | - |
| Other Financing Activities | -183.81 Million | 2.49 Billion | 1.53 Billion | 1.8 Billion | 1.5 Billion | 2.01 Billion |
| Accounts receivables | 690.16 Million | -1.08 Billion | 29.81 Million | -468.26 Million | -305.91 Million | 145.01 Million |
| Accounts payables | -624.13 Million | 112.32 Million | -313.4 Million | -526.3 Million | -490.83 Million | -313.94 Million |
| Inventory | -2.34 Billion | -1.17 Billion | -278.92 Million | 678.3 Million | -269.2 Million | 6.27 Million |
| Other working capital | -1.00 | -28.43 Million | 18.99 Million | -47.9 Million | 1.67 Million | -166.54 Million |
| Cash at beginning of period | 4.59 Billion | 1.68 Billion | 836.67 Million | 573.53 Million | 1.31 Billion | 810.52 Million |
| Cash at end of period | 3.06 Billion | 4.54 Billion | 1.68 Billion | 836.67 Million | 573.53 Million | 1.31 Billion |
| Capital Expenditure | -828.73 Million | -936.18 Million | -1.73 Billion | -197.09 Million | -662.54 Million | -363.56 Million |
| Effect of forex changes on cash | 5.46 Million | 21.85 Million | -10.55 Million | 26.21 Million | 9.29 Million | 36.05 Million |
| Net cash flow / Change in cash | -1.52 Billion | 2.86 Billion | 844.32 Million | 263.13 Million | -737.09 Million | 500.11 Million |
| Free Cash Flow | -627.97 Million | 1.7 Billion | 1.46 Billion | 171.76 Million | -499.62 Million | 580.82 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 29.04 Million | 162.47 Million | 29.79 Million | 264.19 Million | 1.28 Billion | 402.51 Million |
| Depreciation & Amortization | - | 248.41 Million | 248.41 Million | 259.6 Million | 1 Billion | -483.82 Million |
| Deferred income taxes | - | 10.35 Million | - | 1.11 Billion | 80.78 Million | -298.78 Million |
| Stock-based compensation | - | 7.95 Million | - | 29.79 Million | 29.79 Million | -29.79 Million |
| Change in working capital | - | -1.6 Billion | - | -1.65 Billion | -2.28 Billion | 694.79 Million |
| Other non-cash items | -62.78 Million | 406.32 Million | -463.16 Million | -72.14 Million | 4.4 Billion | -476.34 Million |
| Investing Cash Flow | -263.55 Million | -262.09 Million | -239.7 Million | -109.68 Million | -902.65 Million | -234.48 Million |
| Investments in PPE | -211.68 Million | -131.22 Million | -202.09 Million | -183.01 Million | -828.73 Million | -280.38 Million |
| Acquisitions | 9699.00 | 18 Thousand | 2000.00 | 157.32 Million | 91.16 Million | 14.81 Thousand |
| Investment purchases | -27.05 Million | -135.43 Million | -41.44 Million | -83.44 Million | -165.04 Million | -71.31 Million |
| Sales/Maturities of investments | 13.3 Million | 9.27 Million | 4.6 Million | -181.14 Thousand | 120.42 Million | 117.6 Million |
| Other Investing Activities | -38.12 Million | -4.73 Million | 3.83 Million | -556.3 Thousand | -36.3 Thousand | -399.99 Thousand |
| Financing Cash Flow | -182.18 Million | 130.52 Million | 419.36 Million | -644.39 Million | -943.59 Million | 534.18 Million |
| Debt repayment | -87.49 Million | -365.14 Million | -1.01 Billion | -6.6 Million | -147.11 Million | -200 Million |
| Dividends payments | - | -21.32 Million | -16.7 Million | -21.79 Million | -392.63 Million | -15.25 Million |
| Common Stock Repurchased | 944.57 Million | -944.57 Million | - | -500.36 Million | -500.36 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.21 Billion | 714.96 Million | -594.14 Million | -123.53 Million | -183.81 Million | 749.43 Million |
| Accounts receivables | - | -1.35 Billion | - | 690.16 Million | 690.16 Million | -663.37 Million |
| Accounts payables | - | - | - | - | -624.13 Million | - |
| Inventory | - | -250.94 Million | - | -2.34 Billion | -2.34 Billion | 1.35 Billion |
| Other working capital | - | - | - | - | -1.00 | - |
| Cash at beginning of period | 3.06 Billion | 2.78 Billion | 3.06 Billion | 3.88 Billion | 4.59 Billion | 3.63 Billion |
| Cash at end of period | 2.56 Billion | 3.06 Billion | 2.78 Billion | 3.06 Billion | 3.06 Billion | 3.73 Billion |
| Capital Expenditure | -211.68 Million | -131.22 Million | -202.09 Million | -183.01 Million | -828.73 Million | -280.38 Million |
| Effect of forex changes on cash | - | 4.68 Million | -73.73 Thousand | -8.28 Million | 5.46 Million | -3.81 Million |
| Net cash flow / Change in cash | -494.62 Million | 276.55 Million | -279.3 Million | -818.46 Million | -1.52 Billion | 104.44 Million |
| Free Cash Flow | -245.41 Million | 199.5 Million | -635.46 Million | -250.55 Million | -627.97 Million | -471.82 Million |
PREMIERPOL
CAPR
HUMANSOFT
NNOCF
PXMBF
RAMCOIND